Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Blueprint Medi Cm ST (BPMC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,695,712
  • Shares Outstanding, K 43,840
  • Annual Sales, $ 21,430 K
  • Annual Income, $ -148,120 K
  • 36-Month Beta 1.00
  • Price/Sales 165.07
  • Price/Cash Flow N/A
  • Price/Book 6.20

Price Performance

See More
Period Period Low Period High Performance
1-Month
75.73 +10.11%
on 05/10/18
86.46 -3.55%
on 05/16/18
+5.06 (+6.46%)
since 04/25/18
3-Month
75.73 +10.11%
on 05/10/18
109.00 -23.50%
on 03/15/18
-4.63 (-5.26%)
since 02/23/18
52-Week
34.38 +142.55%
on 05/31/17
109.00 -23.50%
on 03/15/18
+45.02 (+117.33%)
since 05/25/17

Most Recent Stories

More News
After Yesterday's Decline of 8.68%, Blueprint Medici Offers Investors Better Value

Blueprint Medici (NASDAQ:BPMC) traded in a range yesterday that spanned from a low of $76.50 to a high of $84.78. Yesterday, the shares fell 8.7%, which took the trading range below the 3-day low of...

BPMC : 83.39 (-1.08%)
Blueprint Medicines Announces Data Presentations at Upcoming ASCO and EHA Meetings Supporting Plans for Rapid Development of Avapritinib in Patients with Gastrointestinal Stromal Tumors and Systemic Mastocytosis

Blueprint Medicines Corporation (NASDAQ: BPMC), a leader in discovering and developing targeted kinase medicines for patients with genomically defined diseases, today announced two data presentations supporting...

BPMC : 83.39 (-1.08%)
Blueprint Medicines Reports First Quarter 2018 Financial Results

Blueprint Medicines Corporation (Nasdaq: BPMC), a leader in discovering and developing targeted kinase medicines for patients with genomically defined diseases, today reported financial results and provided...

BPMC : 83.39 (-1.08%)
Blueprint Medicines Corp. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 2, 2018 / Blueprint Medicines Corp. (NASDAQ: ) will be discussing their earnings results in their Q1 Earnings Call to be held on May 2, 2018 at 8:30 AM Eastern Time.

BPMC : 83.39 (-1.08%)
Report: Developing Opportunities within AMC Networks, JELD-WEN Holding, Blueprint Medicines, Northwest Bancshares, Anika Therapeutics, and Aethlon Medical -- Future Expectations, Projections Moving into 2018

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of AMC Networks Inc. (NASDAQ:AMCX),...

JELD : 28.00 (+1.01%)
ANIK : 40.31 (-2.66%)
NWBI : 17.24 (+0.23%)
AEMD : 1.21 (+0.83%)
BPMC : 83.39 (-1.08%)
AMCX : 59.35 (+1.57%)
Blueprint Medicines to Report First Quarter 2018 Financial Results on Wednesday, May 2, 2018

Blueprint Medicines Corporation (NASDAQ:BPMC), a leader in discovering and developing targeted kinase medicines for patients with genomically defined diseases, today announced that it will host a live...

BPMC : 83.39 (-1.08%)
Watch for Blueprint Medici to Potentially Rebound After Falling 3.51% Yesterday

Blueprint Medici (NASDAQ:BPMC) traded in a range yesterday that spanned from a low of $78.67 to a high of $82.76. Yesterday, the shares fell 3.5%, which took the trading range below the 3-day low of...

BPMC : 83.39 (-1.08%)
Blueprint Medicines Publication in Cancer Discovery Highlights Preclinical and Clinical Proof-of-Concept Data for Highly Selective RET Inhibitor BLU-667

Blueprint Medicines Corporation (NASDAQ:BPMC), a leader in discovering and developing targeted kinase medicines for patients with genomically defined diseases, today announced the online publication of...

BPMC : 83.39 (-1.08%)
Blueprint Medicines Announces Proof-of-Concept Data for Highly Selective RET Inhibitor BLU-667 from Phase 1 ARROW Clinical Trial in Patients with RET-Altered Solid Tumors

Blueprint Medicines Corporation (NASDAQ:BPMC), a leader in discovering and developing targeted kinase medicines for patients with genomically defined diseases, today announced proof-of-concept data from...

BPMC : 83.39 (-1.08%)
Blueprint Medicines Reaches Analyst Target Price

In recent trading, shares of Blueprint Medicines Corp have crossed above the average analyst 12-month target price of $88.00, changing hands for $91.64/share. When a stock reaches the target an analyst...

BPMC : 83.39 (-1.08%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak.

See More Share

Trade BPMC with:

Business Summary

Blueprint Medicines Corp is an oncology company which is engaged in developing kinase inhibitors for genomically defined cancer subsets. Blueprint Medicines Corp is based in Cambridge, MA.

See More

Key Turning Points

2nd Resistance Point 85.60
1st Resistance Point 84.50
Last Price 83.39
1st Support Level 82.57
2nd Support Level 81.74

See More

52-Week High 109.00
Last Price 83.39
Fibonacci 61.8% 80.50
Fibonacci 50% 71.69
Fibonacci 38.2% 62.88
52-Week Low 34.38

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar